Flores, Baby Boy .

HRN: 24-32-42  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2024
AMPICILLIN 250MG (VIAL)
03/10/2024
03/17/2024
IV
175 Mg
Q12
Thickly MSAF
Waiting Final Action 
03/10/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/10/2024
03/17/2024
IV
50 Mg
Q24
Thickly MSAF
Waiting Final Action 
03/10/2024
CEFOTAXIME 500MG (VIAL)
03/10/2024
03/17/2024
IV
175 Mg
Q12
T/c Meconium Aspiration Syndrome
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: